MaaT Pharma SA (EPA:MAAT)
France
· Delayed Price · Currency is EUR 4.160
-0.070 (-1.65%)
At close: Dec 5, 2025
MaaT Pharma Revenue
MaaT Pharma had revenue of 2.43M EUR in the half year ending June 30, 2025, with 76.12% growth. This brings the company's revenue in the last twelve months to 3.92M, up 52.55% year-over-year. In the year 2024, MaaT Pharma had annual revenue of 3.22M with 44.34% growth.
Revenue (ttm)
3.92M
Revenue Growth
+52.55%
P/S Ratio
17.08
Revenue / Employee
60.34K
Employees
67
Market Cap
67.00M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |